389 results
8-K
EX-99.1
WINT
Windtree Therapeutics Inc
17 Apr 24
Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates
7:30am
) a decrease of $0.1 million in personnel costs due to headcount reductions; partially offset by (iv) the reversal of $0.5 million in incentive bonus
8-K
EX-2.1
uek31l4u9fngsu5t
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-3.1
ztdqhdof0t6pzitojfn
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-99.1
vi7o nls90a0jqx7xwxf
9 Nov 23
Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates
4:21pm
424B5
t975 421s5
9 Nov 23
Prospectus supplement for primary offering
4:11pm
S-8
EX-5.1
aaphaoctqaxwf drl05v
30 Aug 23
Registration of securities for employees
4:31pm
S-8
EX-23.3
jjnls2c
30 Aug 23
Registration of securities for employees
4:31pm
S-8
pnb7jdbvtsm 8h
30 Aug 23
Registration of securities for employees
4:31pm
S-8
5p5 2ijqhsr
30 Aug 23
Registration of securities for employees
4:31pm
8-K
6hzyeyewxt5hm2q0d
28 Aug 23
Departure of Directors or Certain Officers
4:15pm